OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cardiovascular and kidney outcomes of spironolactone or eplerenone in combination with ACEI/ARBs in patients with diabetic kidney disease
Jaejin An, Fang Niu, John J. Sim
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2021) Vol. 41, Iss. 12, pp. 998-1008
Closed Access | Times Cited: 13
Jaejin An, Fang Niu, John J. Sim
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2021) Vol. 41, Iss. 12, pp. 998-1008
Closed Access | Times Cited: 13
Showing 13 citing articles:
Cardiovascular Outcomes in Patients With Diabetes and Kidney Disease
Javier Morales, Yehuda Handelsman
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 2, pp. 161-170
Open Access | Times Cited: 34
Javier Morales, Yehuda Handelsman
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 2, pp. 161-170
Open Access | Times Cited: 34
Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction
Chongxiang Xue, Keyu Chen, Zezheng Gao, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 32
Chongxiang Xue, Keyu Chen, Zezheng Gao, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 32
Non-steroidal mineralocorticoid receptor antagonist finerenone ameliorates mitochondrial dysfunction via PI3K/Akt/eNOS signaling pathway in diabetic tubulopathy
Lan Yao, Xianhui Liang, Yamin Liu, et al.
Redox Biology (2023) Vol. 68, pp. 102946-102946
Open Access | Times Cited: 26
Lan Yao, Xianhui Liang, Yamin Liu, et al.
Redox Biology (2023) Vol. 68, pp. 102946-102946
Open Access | Times Cited: 26
Mechanism of Cordyceps sinensis and its Extracts in the Treatment of Diabetic Kidney Disease: A Review
Wu Liu, Yiwei Gao, Yi Zhou, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 36
Wu Liu, Yiwei Gao, Yi Zhou, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 36
Influence of SGLT2i and RAASi and Their Combination on Risk of Hyperkalemia in DKD
Xiaoling Luo, Jing Xu, Shoulian Zhou, et al.
Clinical Journal of the American Society of Nephrology (2023) Vol. 18, Iss. 8, pp. 1019-1030
Closed Access | Times Cited: 18
Xiaoling Luo, Jing Xu, Shoulian Zhou, et al.
Clinical Journal of the American Society of Nephrology (2023) Vol. 18, Iss. 8, pp. 1019-1030
Closed Access | Times Cited: 18
Recent Advances in the Emerging Therapeutic Strategies for Diabetic Kidney Diseases
Wei Huang, Yiyuan Chen, Ziqi Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10882-10882
Open Access | Times Cited: 14
Wei Huang, Yiyuan Chen, Ziqi Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10882-10882
Open Access | Times Cited: 14
Efficacy and safety of finerenone for treatment of diabetic kidney disease: current knowledge and future perspective
Vincenzo Marzolla, Marco Infante, Andrea Armani, et al.
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 9, pp. 1161-1170
Closed Access | Times Cited: 9
Vincenzo Marzolla, Marco Infante, Andrea Armani, et al.
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 9, pp. 1161-1170
Closed Access | Times Cited: 9
Application and design considerations of ROS-based nanomaterials in diabetic kidney disease
Qing Huang, Jiahao Tang, Yunchuan Ding, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1
Qing Huang, Jiahao Tang, Yunchuan Ding, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1
Effectiveness and safety of mineralocorticoid receptor antagonists in heart failure patients with and without diabetes: a systematic review and meta-analysis
Arga Setyo Adji, Jordan Steven Widjaja, Bryan Gervais de Liyis
The Egyptian Heart Journal (2024) Vol. 76, Iss. 1
Open Access | Times Cited: 1
Arga Setyo Adji, Jordan Steven Widjaja, Bryan Gervais de Liyis
The Egyptian Heart Journal (2024) Vol. 76, Iss. 1
Open Access | Times Cited: 1
Optimization of potassium management in patients with chronic kidney disease and type 2 diabetes on finerenone
Alberto Ortíz, Roberto Alcázar Arroyo, Pedro Pablo Casado Escribano, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 6, pp. 519-531
Closed Access | Times Cited: 3
Alberto Ortíz, Roberto Alcázar Arroyo, Pedro Pablo Casado Escribano, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 6, pp. 519-531
Closed Access | Times Cited: 3
Exploring the frontier of cardiovascular pharmacotherapy
William L. Baker, Cynthia A. Jackevicius
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2021) Vol. 41, Iss. 12, pp. 968-969
Closed Access | Times Cited: 1
William L. Baker, Cynthia A. Jackevicius
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2021) Vol. 41, Iss. 12, pp. 968-969
Closed Access | Times Cited: 1
Renoprotective Effects of Angiotensin-Converting Enzyme Inhibitors (Acei) And/Or Angiotensin Ii Receptor Blockers (Arb) in Diabetic Kidney Disease
Yuting Sun, Ziwei Zhang, Wenjie Sun, et al.
(2023)
Closed Access
Yuting Sun, Ziwei Zhang, Wenjie Sun, et al.
(2023)
Closed Access
Cardiovascular Risk Reduction in Diabetes Mellitus, Taking into Account the Updated Recommendations of the Global Initiative to Improve the Results of Treatment of Kidney Diseases
Т.В. Мохорт
Кардиология в Беларуси (2023) Vol. 15, Iss. 6, pp. 825-838
Open Access
Т.В. Мохорт
Кардиология в Беларуси (2023) Vol. 15, Iss. 6, pp. 825-838
Open Access
